| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.21 | 0.3 |